GE HealthCare PET Imaging Radiopharma Agent Flyrcado Gains FDA Approval
GE HealthCare Announces FDA Approval of Flyrcado (Flurpiridaz F 18) Injection PET Radiotracer for Enhanced Diagnosis of Coronary Artery Disease
Express News | GE Healthcare Announces FDA Approval of Flyrcado (Flurpiridaz F 18) Injection Pet Radiotracer for Enhanced Diagnosis of Coronary Artery Disease
Express News | FDA Approves GE Healthcare's Flyrcado - Website
Unusual Options Activity: WYNN, UBS and Others Attract Market Bets, WYNN V/OI Ratio Reaches 222.2
EST Sep 26th Afternoon Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
Siemens Healthineers Cut to Neutral by UBS, Chinese Competition Cited